J. Neal Armstrong serves as Executive at DECODE GENETICS INC, where they oversee executive responsibilities. Since joining the company, J. Neal Armstrong has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2020 involved receiving (via award) 1,398 shares valued at $0.
J. Neal Armstrong currently holds 57,148 shares of DECODE GENETICS INC (DCGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Neal Armstrong has been a net neutral trader of DCGN stock. They have purchased $0 and sold $0 worth of shares.
J. Neal Armstrong's most recent insider trade was on Jan 2, 2020, when they sold 1,398 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $11.62 |
| Discretionary |
| Oct 16, 2019 | VAPO | $16.2K | Award | 1,615 | $10.06 | Discretionary |
| Jul 17, 2019 | VAPO | $16.2K | Award | 837 | $19.40 | Discretionary |
| Apr 12, 2019 | VAPO | $16.2K | Award | 842 | $19.28 | Discretionary |
| Feb 1, 2019 | VAPO | $7.8K | Award | 468 | $16.69 | Discretionary |
| Nov 6, 2009 | ASPM | $477.1K | Tender | 39,760 | $12.00 | Discretionary |
| Nov 6, 2009 | ASPM | $122.8K | Disposition | 10,230 | $12.00 | Discretionary |
| Feb 10, 2009 | ASPM | $0 | Award | 10,230 | $N/A | Discretionary |
| May 29, 2008 | DCGN | $0 | Award | 20,339 | $N/A | Discretionary |
| May 11, 2007 | DCGN | $0 | Award | 6,936 | $N/A | Discretionary |
| May 9, 2006 | DCGN | $0 | Award | 3,252 | $N/A | Discretionary |